Position in EQ
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,040,374
+$726,446 QoQ
Shares Held
637,617
-2.9% QoQ
Ownership
1.01%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#12
of 60 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EQ Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,950,489,724 across 311 Biotechnology names. EQ ranks #131 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,427,993 | $730,617,099 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
5,261,628 | $457,498,554 | |
| 3 | INCY |
Incyte Corp
|
3,512,132 | $398,135,283 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
320,008 | $158,957,573 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
562,073 | $135,442,730 | |
| 6 | RPRX |
Royalty Pharma plc
|
1,935,800 | $108,540,306 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,833,079 | $104,137,217 | |
| 8 | GMAB |
Genmab A/S
|
3,517,850 | $96,635,339 |
All Filings in EQ
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,040,374 | 637,617 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,313,928 | 656,964 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,136,500 | 733,226 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $879,339 | 614,923 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $87,712 | 274,100 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $105,105 | 269,500 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $196,050 | 261,400 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $266,573 | 321,173 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $207,276 | 300,400 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $483,252 | 209,200 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $250,200 | 347,500 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $217,035 | 293,291 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $294,173 | 392,231 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $28,251 | 38,700 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $23,850 | 22,500 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $38,184 | 17,200 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $33,660 | 16,500 | Shares | Sole | 2022-08-12 | |
| 2020-12-31 | $222,073 | 41,509 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $619,403 | 107,349 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $295,439 | 100,149 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $163,811 | 60,447 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||